Cargando…
Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance
Resistance to thyroid hormone (RTH) is a clinical disorder without specific and effective therapeutic strategy, partly due to the lack of structural mechanisms for the defective ligand binding by mutated thyroid hormone receptors (THRs). We herein uncovered the prescription drug roxadustat as a nove...
Autores principales: | Yao, Benqiang, Wei, Yijuan, Zhang, Shuchi, Tian, Siyu, Xu, Shuangshuang, Wang, Rui, Zheng, Weili, Li, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806671/ https://www.ncbi.nlm.nih.gov/pubmed/31655060 http://dx.doi.org/10.1016/j.isci.2019.10.002 |
Ejemplares similares
-
Altered Intracellular Trafficking of Mutant Thyroid Hormone Receptors in Resistance to Thyroid Hormone Syndrome
por: Tofil, Hannah P, et al.
Publicado: (2021) -
The Mutant Thyroid Hormone Receptor Beta R320P Causes Syndrome of Resistance to Thyroid Hormone
por: Kimura, Tetsuya, et al.
Publicado: (2018) -
Repositioning an Immunomodulatory Drug Vidofludimus as a Farnesoid X Receptor Modulator With Therapeutic Effects on NAFLD
por: Zhu, Yanlin, et al.
Publicado: (2020) -
Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant Proteins
por: Moran, Carla, et al.
Publicado: (2017) -
Development of Low-Molecular-Weight Allosteric Agonist of Thyroid-Stimulating Hormone Receptor with Thyroidogenic Activity
por: Bakhtyukov, A. A., et al.
Publicado: (2022)